Bayesian Capital Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bayesian Capital Management’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-60,200	Closed	-$858K	–	833
2018 Q3	$858K	Buy	+60,200	New	+$818K	0.14%	208
2018 Q1	–	Sell	-43,781	Closed	-$637K	–	868
2017 Q4	$637K	Buy	43,781 +400	+0.9%	+$5.56K	0.13%	268
2017 Q3	$617K	Buy	+43,381	New	+$561K	0.15%	225
2016 Q4	–	Sell	-17,990	Closed	-$237K	–	736
2016 Q3	$237K	Buy	+17,990	New	+$241K	0.16%	245
2016 Q1	–	Sell	-19,290	Closed	-$297K	–	458
2015 Q4	$297K	Buy	+19,290	New	+$277K	0.43%	102

Other funds holding MDRX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Bayesian Capital Management's MDRX Position: Q4 2018 in Review

Bayesian Capital Management sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2018, closing a stake of 60,200 shares — an estimated $858K sold.

Bayesian Capital Management first reported a position in MDRX in Q4 2015 and held it in 5 quarters. The position peaked at $858K in Q3 2018. 222 funds tracked by Wall St. Rank hold MDRX as of Q4 2018.

Bayesian Capital Management reported no remaining Veradigm Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Bayesian Capital Management sold 60,200 Veradigm Inc. Common Stock shares in Q4 2018, an estimated $858K.
Bayesian Capital Management first reported a position in Veradigm Inc. Common Stock in Q4 2015 and held it in 5 quarters.
Bayesian Capital Management's Veradigm Inc. Common Stock position peaked at $858K in Q3 2018.
222 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2018.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.